quinacrine has been researched along with Astrocytosis in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ong, WY | 1 |
| Lu, XR | 1 |
| Horrocks, LA | 1 |
| Farooqui, AA | 1 |
| Garey, LJ | 1 |
| Pauri, F | 1 |
| Amabile, G | 1 |
| Fattapposta, F | 1 |
| Pierallini, A | 1 |
| Bianco, F | 1 |
2 other studies available for quinacrine and Astrocytosis
| Article | Year |
|---|---|
Induction of astrocytic cytoplasmic phospholipase A2 and neuronal death after intracerebroventricular carrageenan injection, and neuroprotective effects of quinacrine.
Topics: Animals; Astrocytes; Carrageenan; Cell Death; Disease Progression; Enzyme Induction; Gliosis; Inject | 2003 |
Sporadic Creutzfeldt-Jakob disease without dementia at onset: clinical features, laboratory tests and sequential diffusion MRI (in an autopsy-proven case).
Topics: 14-3-3 Proteins; Brain; Creutzfeldt-Jakob Syndrome; Dementia; Diagnosis, Differential; Diffusion Mag | 2004 |